These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 38436892)

  • 1. Survival mechanisms of circulating tumor cells and their implications for cancer treatment.
    Zhou S; Xu H; Duan Y; Tang Q; Huang H; Bi F
    Cancer Metastasis Rev; 2024 Sep; 43(3):941-957. PubMed ID: 38436892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival Mechanisms and Influence Factors of Circulating Tumor Cells.
    Wang WC; Zhang XF; Peng J; Li XF; Wang AL; Bie YQ; Shi LH; Lin MB; Zhang XF
    Biomed Res Int; 2018; 2018():6304701. PubMed ID: 30515411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shear stress activates ATOH8 via autocrine VEGF promoting glycolysis dependent-survival of colorectal cancer cells in the circulation.
    Huang Q; Li S; Hu X; Sun M; Wu Q; Dai H; Tan Y; Sun F; Wang C; Rong X; Liao W; Peng J; Xiao J; Huang L; Wang J; Liang B; Lin K; Liu Y; Shi M
    J Exp Clin Cancer Res; 2020 Jan; 39(1):25. PubMed ID: 32000836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravascular Survival and Extravasation of Tumor Cells.
    Strilic B; Offermanns S
    Cancer Cell; 2017 Sep; 32(3):282-293. PubMed ID: 28898694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Squeezing through the microcirculation: survival adaptations of circulating tumour cells to seed metastasis.
    Perea Paizal J; Au SH; Bakal C
    Br J Cancer; 2021 Jan; 124(1):58-65. PubMed ID: 33257836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinguishing high-metastasis-potential circulating tumor cells through fluidic shear stress in a bloodstream-like microfluidic circulatory system.
    Li W; Guo Z; Zhou Z; Zhou Z; He H; Sun J; Zhou X; Chin YR; Zhang L; Yang M
    Oncogene; 2024 Jul; 43(30):2295-2306. PubMed ID: 38858591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular Mechanisms of Circulating Tumor Cells During Breast Cancer Metastasis.
    Park HA; Brown SR; Kim Y
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating tumor cell-blood cell crosstalk: Biology and clinical relevance.
    Pereira-Veiga T; Schneegans S; Pantel K; Wikman H
    Cell Rep; 2022 Aug; 40(9):111298. PubMed ID: 36044866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and biological significance of circulating tumor cells in cancer.
    Masuda T; Hayashi N; Iguchi T; Ito S; Eguchi H; Mimori K
    Mol Oncol; 2016 Mar; 10(3):408-17. PubMed ID: 26899533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S-Nitrosocaptopril prevents cancer metastasis in vivo by creating the hostile bloodstream microenvironment against circulating tumor cells.
    Lu Y; Lian S; Ye Y; Yu T; Liang H; Cheng Y; Xie J; Zhu Y; Xie X; Yu S; Gao Y; Jia L
    Pharmacol Res; 2019 Jan; 139():535-549. PubMed ID: 30366102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating tumor cells as Trojan Horse for understanding, preventing, and treating cancer: a critical appraisal.
    Mentis AA; Grivas PD; Dardiotis E; Romas NA; Papavassiliou AG
    Cell Mol Life Sci; 2020 Sep; 77(18):3671-3690. PubMed ID: 32333084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stem-like plasticity and heterogeneity of circulating tumor cells: current status and prospect challenges in liver cancer.
    Correnti M; Raggi C
    Oncotarget; 2017 Jan; 8(4):7094-7115. PubMed ID: 27738343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Role of Effector CD
    Mahasa KJ; Ouifki R; de Pillis L; Eladdadi A
    Bull Math Biol; 2024 Jun; 86(8):89. PubMed ID: 38884815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating tumor cells in cancer patients: developments and clinical applications for immunotherapy.
    Zhong X; Zhang H; Zhu Y; Liang Y; Yuan Z; Li J; Li J; Li X; Jia Y; He T; Zhu J; Sun Y; Jiang W; Zhang H; Wang C; Ke Z
    Mol Cancer; 2020 Jan; 19(1):15. PubMed ID: 31980023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cooperative and Escaping Mechanisms between Circulating Tumor Cells and Blood Constituents.
    Garrido-Navas C; de Miguel-Perez D; Exposito-Hernandez J; Bayarri C; Amezcua V; Ortigosa A; Valdivia J; Guerrero R; Garcia Puche JL; Lorente JA; Serrano MJ
    Cells; 2019 Nov; 8(11):. PubMed ID: 31684193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NK cells-directed therapies target circulating tumor cells and metastasis.
    Dianat-Moghadam H; Mahari A; Heidarifard M; Parnianfard N; Pourmousavi-Kh L; Rahbarghazi R; Amoozgar Z
    Cancer Lett; 2021 Jan; 497():41-53. PubMed ID: 32987138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimal Residual Disease, Metastasis and Immunity.
    Badia-Ramentol J; Linares J; Gómez-Llonin A; Calon A
    Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33498251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating tumor cell as the functional aspect of liquid biopsy to understand the metastatic cascade in solid cancer.
    Cortés-Hernández LE; Eslami-S Z; Alix-Panabières C
    Mol Aspects Med; 2020 Apr; 72():100816. PubMed ID: 31377345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LKB1 pro-oncogenic activity triggers cell survival in circulating tumor cells.
    Trapp EK; Majunke L; Zill B; Sommer H; Andergassen U; Koch J; Harbeck N; Mahner S; Friedl TWP; Janni W; Rack B; Alunni-Fabbroni M
    Mol Oncol; 2017 Nov; 11(11):1508-1526. PubMed ID: 28700115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physical biology in cancer. 2. The physical biology of circulating tumor cells.
    Phillips KG; Kuhn P; McCarty OJ
    Am J Physiol Cell Physiol; 2014 Jan; 306(2):C80-8. PubMed ID: 24133063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.